COVID-19 triggering mucormycosis in a susceptible patient: A new phenomenon in the developing world?

159Citations
Citations of this article
181Readers
Mendeley users who have this article in their library.

Abstract

A middle-aged woman with diabetes presented with left-sided facial pain, complete ptosis and fever of short duration. On presentation, she had hyperglycaemia without ketosis. There was total ophthalmoplegia of the left eye with a visual acuity of 6/36. She incidentally tested positive for COVID-19. CT paranasal sinus and MRI brain revealed left-sided pansinusitis with acute infarct in the left parieto-occipital region without angioinvasion. An emergency functional endoscopic sinus procedure was done, which confirmed mucormycosis on histopathological examination. After 1 week of conventional amphotericin B and antibiotics, repeat CT brain showed improvement in mucosal thickening and sinusitis. This case is a rare presentation of mucormycosis associated with rapid progression to orbital apex syndrome with brain infarction in a patient with non-ketotic diabetes and COVID-19. Early diagnosis and treatment are essential to prevent further end-organ damage. It is also interesting that there was no angioinvasion and transient periarterial inflammation was attributed to brain infarction.

Cite

CITATION STYLE

APA

Revannavar, S. M., Supriya, P., Samaga, L., & Vineeth, K. (2021). COVID-19 triggering mucormycosis in a susceptible patient: A new phenomenon in the developing world? BMJ Case Reports, 14(4). https://doi.org/10.1136/bcr-2021-241663

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free